Effect of Deep Tissue Laser Therapy Treatment on Peripheral Neuropathic Pain in Older Adults with Type 2 Diabetes: A Pilot Randomized Clinical Trial
This randomized, double-blind, sham-controlled, interventional pilot study assessed the safety and efficacy of deep tissue laser therapy on the management of pain, functionality, systemic inflammation, and overall quality of life of older adults with painful diabetic peripheral neuropathy. The study concluded that deep tissue laser therapy significantly reduced pain and improved the overall quality of life of older adults with painful diabetic peripheral neuropathy. Given the non-invasive nature of the intervention, its high compliance rate, and its safety profile (i.e., no known adverse or side effects), deep tissue laser therapy should be considered a safe, nonpharmacological addition to the standard of care for the management of pain in older adults with painful diabetic peripheral neuropathy.
Published: BMC Geriatrics, August 12, 2019;19 (218). doi: 10.1186/s12877-019-1237-5
Keywords: Diabetic peripheral neuropathy, Older adults, Deep tissue laser therapy, Inflammatory markers